Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash from Financing Activities (2016 - 2025)

STRATA Skin Sciences' Cash from Financing Activities history spans 14 years, with the latest figure at $1.4 million for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities changed N/A to $1.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 85.92% increase, with the full-year FY2025 number at $3.6 million, up 85.92% from a year prior.
  • Cash from Financing Activities hit $1.4 million in Q4 2025 for STRATA Skin Sciences, down from $2.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for SSKN hit a ceiling of $7.0 million in Q2 2023 and a floor of -$500000.0 in Q4 2022.
  • Historically, Cash from Financing Activities has averaged $1.5 million across 5 years, with a median of $739500.0 in 2021.
  • Biggest five-year swings in Cash from Financing Activities: surged 1968.27% in 2024 and later rose 12.82% in 2025.
  • Tracing SSKN's Cash from Financing Activities over 5 years: stood at $92000.0 in 2021, then tumbled by 643.48% to -$500000.0 in 2022, then skyrocketed by 79.2% to -$104000.0 in 2023, then surged by 1968.27% to $1.9 million in 2024, then fell by 28.62% to $1.4 million in 2025.
  • Business Quant data shows Cash from Financing Activities for SSKN at $1.4 million in Q4 2025, $2.2 million in Q3 2025, and $1.9 million in Q3 2024.